For those who are considering GLP-1s, it helps to understand what is FDA-approved today, what the results look like on average, and what tradeoffs come with pills versus injections
Triple receptor activity: GLP-1, GIP, and glucagon Appetite and satiety pathway support Energy expenditure and fat metabolism research Body weight reduction in clinical trials Potential metabolic health improvements A possible future option for clients who have plateaued on existing therapies In a phase 2 trial published in The New England Journal of Medicine, adults with obesity who received Retatrutide for 48 weeks had substantial reductions in body weight, with the 12 mg group showing a mean percentage change of -24.2% compared with -2.1% for placebo
Swirl some nut butter into your morning oats and top it with berries for a one-two punch, throw some frozen sweet potato fries into the air fryer to serve with your turkey burger, or add a handful of nuts to your afternoon snack
Due to its proven benefits for appetite control, Ozempic is now frequently prescribed under careful medical supervision for patients seeking to manage their weight effectively and safely
New Research: GLP-1 Medications and Broader Health Benefits A large-scale study using U.S